To study concurrent chemoradiation comparing by cisplatin 20 mg/m2 5 days every four weekly versus standard 100 mg/m2 three weekly in locally advanced head and neck cancer (LAHNC) patients. - Current Issue

To study concurrent chemoradiation comparing by cisplatin 20 mg/m2 5 days every four weekly versus standard 100 mg/m2 three weekly in locally advanced head and neck cancer (LAHNC) patients. - Current Issue - IJSR